FDA Inspection 1177562 — Axogen Corporation
The FDA completed an inspection of Axogen Corporation on July 28, 2022 in Burleson, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 28, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Burleson, TX (United States)